Eicosanoid production from porcine neutrophils and platelets: Differential production with various agonists

American Journal of Physiology - Cell Physiology

Volumn 272, Issue 6 41-6, 1997, Pages

  Stahl, Gregory L ^a,b   Morse, David S ^a   Martin, Shane L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

A 23187; C5a; Lipoxins; Thromboxane

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; CALCIMYCIN; COMPLEMENT COMPONENT C5A; ICOSANOID; LIPOXIN A; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL CELL; ARTICLE; ICOSANOID METABOLISM; IMMUNOMODULATION; INFLAMMATION; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOCYTE ACTIVATION;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0030742251     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1997.272.6.c1821     Document Type: Article

References (18)

1. Amsterdam, E. A., G. L. Stahl, H.-L. Pan, S. V. Rendig, M. P. Fletcher, and J. C. Longhurst. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H448-H457, 1995.
2. Chenoweth, D. E., T. A. Lane, J. G. Rowe, and T. E. Hugli. Quantitative comparisons of neutrophil chemotaxis in four animal species. Clin. Immunol. Immunopathol. 15: 525-535, 1980.
3. Coeffier, E., D. Joseph, M.-C. Prevost, and B. B. Vargaftig. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils. Br. J. Pharmacol. 92: 393-406, 1987.
4. Cui, L., D. F. Carney, and T. E. Hugli. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency. Protein Sci. 3: 1169-1177, 1994.
5. Deinhart, T., J. Wang, K. Toy, A. Ishizaka, K. E. Stephens, E. W. Hall, T. A. Raffin, D. E. Chenoweth, S. L. Kunkel, and J. W. Larrick. Murine monoclonal antibodies neutralizing the effects of porcine C5a. In: The Pharmacology and Toxicology of Proteins, edited by J. L. Winkelhake and J. S. Holcenberg. New York: Alan R. Liss, 1987, p. 255-272.
6. Evangelista, V., G. Rajtar, G. De Gaetano, J. G. White, and C. Cerletti. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. Blood 77: 2379-2388, 1991.
7. Ferrer-Lopez, P., P. Renesto, M. Schattner, S. Bassot, P. Laurent, and M. Chignard. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Am. J. Physiol. 258 (Cell Physiol. 27): C1100-C1107, 1990.
8. Fiore, S., M. E. Brezinski, L.-A. Shephard, and C. N. Serhan. The lipoxin biosynthetic circuit and their actions with human neutrophils. In: Cell-Cell Interactions in the Release of Inflammatory Mediators, edited by P. Y.-K. Wong and C. N. Serhan. New York: Plenum, 1991, p. 109-132.
9. Fletcher, M. P., G. L. Stahl, and J. C. Longhurst. In vivo and in vitro assessment of porcine neutrophil activation responses to chemoattractants: flow cytometric evidence for the selective absence of formyl peptide receptors. J. Leukoc. Biol. 47: 355-365, 1990.
10. Fletcher, M. P., G. L. Stahl, and J. C. Longhurst. C5a-induced myocardial ischemia: role for CD18-dependent PMN localization and PMN-platelet interactions. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1750-H1761, 1993.
11. Gerard, C., and T. E. Hugli. Amino acid sequencing the anaphylatoxin for the fifth component of porcine complement. J. Biol. Chem. 255: 4710-4715, 1980.
12. Hada, T., N. Ueda, Y. Takahashi, and S. Yamamoto. Catalytic properties of human platelet 12-lipoxygenase as compared with the enzymes of other origins. Biochim. Biophys. Acta 1083: 89-93, 1991.
13. Hespeling, U., G. P. Püschel, K. Jungermann, O. Götze, and J. Zwirner. Stimulation of glycogen phosphorylase in rat hepatocytes via prostanoid release from Kupffer cells by recombinant rat anaphylatoxin C5a but not by native human C5a in hepatocyte Kupffer cell co-cultures. FEBS Lett. 372: 108-112, 1995.
14. Hugli, T. E., C. Gerard, M. Kawahara, M. E. Schoetz II., R. Barton, S. Briggs, G. Koppel, and S. Russell. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol. Cell. Biochem. 41: 59-66, 1981.
15. 2) releases lipoxins and leukotrienes from endogenous sources. Ann. NY Acad. Sci. 524: 27-34, 1988.
16. 2 isoenzyme provokes lipoxin B formation from endogenous sources of arachidonic acid in porcine leukocytes. Biochem. Biophys. Res. Commun. 144: 123-131, 1987.
17. 4: comparison of icosanoids having bronchoconstrictor and vasodilator actions but lacking platelet aggregatory activity. Proc. Natl. Acad. Sci. USA 85: 8340-8344, 1988.
18. Marcus, A. J., M. J. Broekman, L. B. Safier, H. L. Ullman, N. Islam, C. N. Serhan, L. E. Rutherford, H. M. Korchak, and G. Weissmann. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem. Biophys. Res. Commun. 109: 130-138, 1982.